LGND: Ligand Pharmaceuticals Incorporated - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Ligand Pharmaceuticals Incorporated from Zacks Investment Research LGND: Ligand Pharmaceuticals Incorporated broker recommendations. Get the latest broker recommendations from Zacks Investment Research. Should Value Investors Buy Ligand Pharmaceuticals (LGND) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great Find the latest Ligand Pharmaceuticals Incorpor (LGND) stock quote, history, news and other vital information to help you with your stock trading and investing. Stocks with both "A" grades in the Value category and high Zacks Ranks are among the strongest value stocks on the market right now. Ligand Pharmaceuticals (LGND - Free Report) is a stock many LGND vs. TECH: Which Stock Is the Better Value Option? May. 7, 2020 at 11:40 a.m. ET on Zacks.com Ligand (LGND) Beats on Q1 Earnings & Sales, Raises View
LGND - Ligand Pharmaceuticals Incorporated Summary, Stock ... Jan 01, 2010
Ligand Pharmaceuticals News | Markets Insider Ligand Pharmaceuticals (LGND) Stock Sinks As Market Gains: What You Should Know Zacks 599d Time to Focus on Ligand Pharmaceuticals (LGND) for Strong Earnings Growth Potential
Ligand Pharmaceuticals - LGND - Stock Price & News | The ... Real time Ligand Pharmaceuticals (LGND) stock price quote, stock graph, news & analysis. LGND - Ligand Pharm Stock Price - Barchart.com Ligand Pharmaceuticals (LGND) Q1 Earnings and Revenues Beat Estimates Zacks Equity Research - Zacks Investment Research - Wed May 6, 4:45PM CDT Zacks Equity Research - ZACKS - Wed May 6, 4:45PM CDT Ligand (LGND) delivered earnings and revenue surprises of 45.90% and 27.30%, respectively, for the quarter ended March 2020. Ligand Pharmaceuticals News | Markets Insider
LGND -- Is Its Stock Price A Worthy Investment? Learn More. LGND Stock Summary. With a price/sales ratio of 14.92, Ligand Pharmaceuticals Inc has a higher such ratio than 91.49% of stocks in our set. Revenue growth over the past 12 months for Ligand Pharmaceuticals Inc comes in at -53.95%, a number that bests only 3.06% of the US stocks we're tracking. Ligand (LGND) Q4 Earnings & Revenues Top Estimates, Stock Up Ligand Pharmaceuticals Incorporated LGND reported fourth-quarter 2019 adjusted earnings of 71 cents per share, which beat the Zacks Consensus Estimate of 68 cents.The company had reported adjusted earnings of $1.70 in the year-ago quarter. Fourth-quarter adjusted earnings exclude the impact of non-cash charge of $8.5 million related to Ligand’s investment in Viking Therapeutics, stock-based LGND Stock Price and Chart — NASDAQ:LGND — TradingView View live LIGAND PHARMACEUTICAL INC chart to track its stock's price action. Find market predictions, LGND financials and market news.